Literature DB >> 25512168

Idiopathic interstitial pneumonias: a radiology-pathology correlation based on the revised 2013 American Thoracic Society-European Respiratory Society classification system.

Michael A Kadoch1, Matthew D Cham2, Mary B Beasley3, Thomas J Ward4, Adam H Jacobi4, Corey D Eber4, Maria L Padilla5.   

Abstract

The idiopathic interstitial pneumonias (IIPs) are a group of diffuse lung diseases that share many similar radiologic and pathologic features. According to the revised 2013 American Thoracic Society-European Respiratory Society classification system, these entities are now divided into major IIPs (idiopathic pulmonary fibrosis, idiopathic nonspecific interstitial pneumonia, respiratory bronchiolitis-associated interstitial lung disease, desquamative interstitial pneumonia, cryptogenic organizing pneumonia, and acute interstitial pneumonia), rare IIPs (idiopathic lymphoid interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis), and unclassifiable idiopathic interstitial pneumonias. Some of the encountered radiologic and histologic patterns can also be seen in the setting of other disorders, which makes them a diagnostic challenge. As such, the accurate classification of IIPs remains complex and is best approached through a collaboration among clinicians, radiologists, and pathologists, as the treatment and prognosis of these conditions vary greatly.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25512168     DOI: 10.1067/j.cpradiol.2014.07.005

Source DB:  PubMed          Journal:  Curr Probl Diagn Radiol        ISSN: 0363-0188


  9 in total

1.  Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.

Authors:  Jarushka Naidoo; Xuan Wang; Kaitlin M Woo; Tunc Iyriboz; Darragh Halpenny; Jane Cunningham; Jamie E Chaft; Neil H Segal; Margaret K Callahan; Alexander M Lesokhin; Jonathan Rosenberg; Martin H Voss; Charles M Rudin; Hira Rizvi; Xue Hou; Katherine Rodriguez; Melanie Albano; Ruth-Ann Gordon; Charles Leduc; Natasha Rekhtman; Bianca Harris; Alexander M Menzies; Alexander D Guminski; Matteo S Carlino; Benjamin Y Kong; Jedd D Wolchok; Michael A Postow; Georgina V Long; Matthew D Hellmann
Journal:  J Clin Oncol       Date:  2016-09-30       Impact factor: 44.544

2.  Risk factors for pneumonitis in patients treated with anti-programmed death-1 therapy: A case-control study.

Authors:  Pengfei Cui; Zhefeng Liu; Guoqiang Wang; Junxun Ma; Yuanyu Qian; Fan Zhang; Chun Han; Yaping Long; Ye Li; Xuan Zheng; Danyang Sun; Jing Zhang; Shangli Cai; Shunchang Jiao; Yi Hu
Journal:  Cancer Med       Date:  2018-05-23       Impact factor: 4.452

3.  Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome.

Authors:  Tetsuro Araki; Suzanne E Dahlberg; Tomoyuki Hida; Christine A Lydon; Michael S Rabin; Hiroto Hatabu; Bruce E Johnson; Mizuki Nishino
Journal:  Eur J Radiol Open       Date:  2019-03-29

Review 4.  Immunotherapy Associated Pulmonary Toxicity: Biology Behind Clinical and Radiological Features.

Authors:  Michele Porcu; Pushpamali De Silva; Cinzia Solinas; Angelo Battaglia; Marina Schena; Mario Scartozzi; Dominique Bron; Jasjit S Suri; Karen Willard-Gallo; Dario Sangiolo; Luca Saba
Journal:  Cancers (Basel)       Date:  2019-03-05       Impact factor: 6.639

Review 5.  Transformation of lymphoid interstitial pneumonia (LIP) into malignant lymphoma in patients with Sjogren's syndrome: a case report and literature review.

Authors:  Chengyuan Zhu; Jibo Hu; Jun Wu; Lingxiao Cheng
Journal:  J Cardiothorac Surg       Date:  2022-04-15       Impact factor: 1.637

6.  Pleuroparenchymal Fibroelastosis: A New Entity within the Spectrum of Rare Idiopathic Interstitial Pneumonias.

Authors:  Karina Portillo; Ignasi Guasch; Caroline Becker; Felipe Andreo; Maria Teresa Fernández-Figueras; José Ramirez Ruz; Carlos Martinez-Barenys; Samuel García-Reina; Pedro Lopez de Castro; Irene Sansano; Ana Villar; Juan Ruiz-Manzano
Journal:  Case Rep Pulmonol       Date:  2015-08-26

7.  Prognostic significance of the radiologic features of pneumonitis induced by anti-PD-1 therapy.

Authors:  Satoshi Watanabe; Takeshi Ota; Masachika Hayashi; Hiroyuki Ishikawa; Aya Otsubo; Satoshi Shoji; Koichiro Nozaki; Kosuke Ichikawa; Rie Kondo; Takao Miyabayashi; Satoru Miura; Hiroshi Tanaka; Tetsuya Abe; Masaaki Okajima; Masaki Terada; Takashi Ishida; Akira Iwashima; Kazuhiro Sato; Hirohisa Yoshizawa; Toshiaki Kikuchi
Journal:  Cancer Med       Date:  2020-03-09       Impact factor: 4.452

8.  Clinical characteristics and management of immune checkpoint inhibitor-related pneumonitis: A single-institution retrospective study.

Authors:  Hanping Wang; Yanwei Zhao; Xiaotong Zhang; Xiaoyan Si; Peng Song; Yi Xiao; Xu Yang; Lan Song; Juhong Shi; Haitao Zhao; Li Zhang
Journal:  Cancer Med       Date:  2020-11-19       Impact factor: 4.452

9.  Synergistic combination of a topologically invariant imaging signature and a biomarker for the accurate prediction of symptomatic radiation pneumonitis before stereotactic ablative radiotherapy for lung cancer: A retrospective analysis.

Authors:  Kenta Ninomiya; Hidetaka Arimura; Tadamasa Yoshitake; Taka-Aki Hirose; Yoshiyuki Shioyama
Journal:  PLoS One       Date:  2022-01-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.